LJI investigator Matthias von Herrath, M.D.   leads the fight against type 1 diabetes from two fronts: He heads the Diabetes and Immune Disease National Research Institute and, at the same time, directs a translational diabetes center in Seattle run by the Danish healthcare company Novo Nordisk.

When in Seattle, von Herrath focuses on developing immunotherapy for diabetes, while at DIDNRI he conducts basic research into its molecular and cellular underpinnings. Many of his studies are conducted in partnership with the Network for Pancreatic Organ donors with Diabetes (nPOD), which provides pancreatic tissues from diabetic organ donors to researchers at leading diabetes centers.